MindMaze Therapeutics starts SwissNeuroRehab study, launches France’s REACT-AVC

The company said the Swiss and French stroke rehabilitation studies are meant to build clinical and health-economic evidence for at-home reimbursement across key European markets.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.